NT5C3
From Wikipedia, the free encyclopedia
5'-nucleotidase, cytosolic III
|
||||||||||||||
PDB rendering based on 2bdu. | ||||||||||||||
Available structures: 2bdu, 2cn1, 2g06, 2g07, 2g08, 2g09, 2g0a, 2jga | ||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | NT5C3; PN-I; MGC27337; MGC87109; MGC87828; P5'N-1; PSN1; UMPH; UMPH1; cN-III | |||||||||||||
External IDs | OMIM: 606224 MGI: 1927186 HomoloGene: 9534 | |||||||||||||
|
||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 51251 | 107569 | ||||||||||||
Ensembl | ENSG00000122643 | ENSMUSG00000029780 | ||||||||||||
Uniprot | Q9H0P0 | Q9D020 | ||||||||||||
Refseq | NM_001002009 (mRNA) NP_001002009 (protein) |
NM_026004 (mRNA) NP_080280 (protein) |
||||||||||||
Location | Chr 7: 33.02 - 33.07 Mb | Chr 6: 56.81 - 56.85 Mb | ||||||||||||
Pubmed search | [1] | [2] |
5'-nucleotidase, cytosolic III, also known as NT5C3, is a human gene.[1]
Pyrimidine 5-prime-nucleotidase (P5N; EC 3.1.3.5), also called uridine 5-prime monophosphate hydrolase (UMPH), catalyzes the dephosphorylation of the pyrimidine 5-prime monophosphates UMP and CMP to the corresponding nucleosides. There are 2 isozymes of pyrimidine 5-prime nucleotidase in red blood cells, referred to as type I (UMPH1) and type II (UMPH2; MIM 191720). The 2 enzymes are not separable by electrophoresis in humans but have distinct kinetic properties, and the proteins show no homology.[supplied by OMIM][1]
[edit] References
[edit] Further reading
- Amici A, Emanuelli M, Ferretti E, et al. (1995). "Homogeneous pyrimidine nucleotidase from human erythrocytes: enzymic and molecular properties.". Biochem. J. 304 ( Pt 3): 987–92. PMID 7818506.
- Rich SA, Bose M, Tempst P, Rudofsky UH (1996). "Purification, microsequencing, and immunolocalization of p36, a new interferon-alpha-induced protein that is associated with human lupus inclusions.". J. Biol. Chem. 271 (2): 1118–26. PMID 8557639.
- Hillier LD, Lennon G, Becker M, et al. (1997). "Generation and analysis of 280,000 human expressed sequence tags.". Genome Res. 6 (9): 807–28. PMID 8889549.
- Amici A, Emanuelli M, Magni G, et al. (1998). "Pyrimidine nucleotidases from human erythrocyte possess phosphotransferase activities specific for pyrimidine nucleotides.". FEBS Lett. 419 (2-3): 263–7. PMID 9428647.
- Amici A, Emanuelli M, Raffaelli N, et al. (2000). "Human erythrocyte pyrimidine 5-nucleotidase, PN-I, is identical to p36, a protein associated to lupus inclusion formation in response to alpha-interferon.". Blood 96 (4): 1596–8. PMID 10942414.
- Zhang QH, Ye M, Wu XY, et al. (2001). "Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.". Genome Res. 10 (10): 1546–60. PMID 11042152.
- Hartley JL, Temple GF, Brasch MA (2001). "DNA cloning using in vitro site-specific recombination.". Genome Res. 10 (11): 1788–95. PMID 11076863.
- Wiemann S, Weil B, Wellenreuther R, et al. (2001). "Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.". Genome Res. 11 (3): 422–35. doi: . PMID 11230166.
- Marinaki AM, Escuredo E, Duley JA, et al. (2001). "Genetic basis of hemolytic anemia caused by pyrimidine 5' nucleotidase deficiency.". Blood 97 (11): 3327–32. PMID 11369620.
- Amici A, Magni G (2002). "Human erythrocyte pyrimidine 5'-nucleotidase, PN-I.". Arch. Biochem. Biophys. 397 (2): 184–90. doi: . PMID 11795870.
- Amici A, Emanuelli M, Ruggieri S, et al. (2003). "Kinetic evidence for covalent phosphoryl-enzyme intermediate in phosphotransferase activity of human red cell pyrimidine nucleotidases.". Meth. Enzymol. 354: 149–59. PMID 12418222.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Balta G, Gumruk F, Akarsu N, et al. (2003). "Molecular characterization of Turkish patients with pyrimidine 5' nucleotidase-I deficiency.". Blood 102 (5): 1900–3. doi: . PMID 12714505.
- Bianchi P, Fermo E, Alfinito F, et al. (2003). "Molecular characterization of six unrelated Italian patients affected by pyrimidine 5'-nucleotidase deficiency.". Br. J. Haematol. 122 (5): 847–51. PMID 12930399.
- Kanno H, Takizawa T, Miwa S, Fujii H (2004). "Molecular basis of Japanese variants of pyrimidine 5'-nucleotidase deficiency.". Br. J. Haematol. 126 (2): 265–71. doi: . PMID 15238149.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.
- Wiemann S, Arlt D, Huber W, et al. (2004). "From ORFeome to biology: a functional genomics pipeline.". Genome Res. 14 (10B): 2136–44. doi: . PMID 15489336.
- Chiarelli LR, Bianchi P, Fermo E, et al. (2005). "Functional analysis of pyrimidine 5'-nucleotidase mutants causing nonspherocytic hemolytic anemia.". Blood 105 (8): 3340–5. doi: . PMID 15604219.
- Mehrle A, Rosenfelder H, Schupp I, et al. (2006). "The LIFEdb database in 2006.". Nucleic Acids Res. 34 (Database issue): D415–8. doi: . PMID 16381901.